Viewing Study NCT00083057


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-02-17 @ 4:24 PM
Study NCT ID: NCT00083057
Status: COMPLETED
Last Update Posted: 2012-03-15
First Post: 2004-05-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
Sponsor: National Institutes of Health Clinical Center (CC)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III squamous cell carcinoma of the lip and oral … View
None stage IV squamous cell carcinoma of the lip and oral … View
None recurrent squamous cell carcinoma of the lip and oral cavity View
None stage III squamous cell carcinoma of the hypopharynx View
None stage IV squamous cell carcinoma of the hypopharynx View
None recurrent squamous cell carcinoma of the hypopharynx View
None stage III squamous cell carcinoma of the oropharynx View
None stage IV squamous cell carcinoma of the oropharynx View
None recurrent squamous cell carcinoma of the oropharynx View
None recurrent squamous cell carcinoma of the nasopharynx View
None stage III squamous cell carcinoma of the nasopharynx View
None stage IV squamous cell carcinoma of the nasopharynx View
None recurrent squamous cell carcinoma of the paranasal sinus and nasal … View
None recurrent squamous cell carcinoma of the larynx View
None stage III squamous cell carcinoma of the larynx View
None stage IV squamous cell carcinoma of the larynx View